CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex.
作者信息
Boriani Giuseppe, Vitolo Marco, Mei Davide A
机构信息
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena 41124, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
出版信息
Europace. 2024 Nov 1;26(11). doi: 10.1093/europace/euae281.
Abstract
摘要
相似文献
1
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex.房颤患者卒中风险分层采用CHA2DS2-VA而非CHA2DS2-VASc：不仅仅是性别的问题。
Europace. 2024 Nov 1;26(11). doi: 10.1093/europace/euae281.
2
Comparing CHADS-VA and CHADS-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.比较CHADS-VA和CHADS-VASc评分在房颤患者卒中风险分层中的应用：来自芬兰房颤抗凝（FinACAF）回顾性队列的时间趋势分析
Lancet Reg Health Eur. 2024 Jun 10;43:100967. doi: 10.1016/j.lanepe.2024.100967. eCollection 2024 Aug.
3
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHADS-VA Score Rather Than CHADS-VASc?女性性别是房颤卒中的风险修饰因素而非风险因素：我们是否应该使用 CHADS-VA 评分而不是 CHADS-VASc？
Circulation. 2018 Feb 20;137(8):832-840. doi: 10.1161/CIRCULATIONAHA.117.029081.
4
Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.伴有高合并症负担的心房颤动患者的早期节律控制。
Circulation. 2022 Sep 13;146(11):836-847. doi: 10.1161/CIRCULATIONAHA.122.060274. Epub 2022 Aug 15.
5
Validation of the CHA2DS2-VA Score (Excluding Female Sex) in Nonvalvular Atrial Fibrillation Patients: A Nationwide Population-Based Study.非瓣膜性心房颤动患者CHA2DS2-VA评分（不包括女性性别）的验证：一项基于全国人群的研究。
J Clin Med. 2022 Mar 25;11(7):1823. doi: 10.3390/jcm11071823.
6
Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.日本非瓣膜性心房颤动患者中排除女性性别因素的CHA2DS2-VASc风险评分系统的验证——J-RHYTHM注册研究的亚分析
Circ J. 2015;79(8):1719-26. doi: 10.1253/circj.CJ-15-0095. Epub 2015 May 13.
7
Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution.女性性别是房颤中风风险的修饰因素：使用 CHA2DS2-VASc 与 CHA2DS2-VA 对房颤中风风险进行分层：注意事项。
Thromb Haemost. 2020 Jun;120(6):894-898. doi: 10.1055/s-0040-1710014. Epub 2020 Apr 21.
8
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?CHA2DS2-VASc 是否能改善绝经后女性心房颤动患者的卒中风险分层？
Am J Med. 2013 Dec;126(12):1143.e1-8. doi: 10.1016/j.amjmed.2013.05.023. Epub 2013 Oct 17.
9
Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.验证改良 CHA2DS2-VASc 评分在亚洲房颤患者中风风险分层中的应用：一项全国性队列研究。
Stroke. 2016 Oct;47(10):2462-9. doi: 10.1161/STROKEAHA.116.013880. Epub 2016 Sep 13.
10
CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.CHA2DS2-VASc 评分与房颤患者的肺栓塞风险直接相关。
Am J Med. 2014 Jan;127(1):45-52. doi: 10.1016/j.amjmed.2013.10.004. Epub 2013 Oct 15.
引用本文的文献
1
Risk factors and predictive model for gastrointestinal bleeding in patients with ischemic stroke: a case-control study.缺血性脑卒中患者胃肠道出血的危险因素及预测模型：一项病例对照研究。
Am J Transl Res. 2025 Jul 15;17(7):5011-5024. doi: 10.62347/EOOS8728. eCollection 2025.
2
Stroke Risk Stratification in Incident Atrial Fibrillation: A Sex-Specific Evaluation of CHA2DS2-VA and CHA2DS2-VASc.新发房颤患者的卒中风险分层：CHA2DS2-VA和CHA2DS2-VASc的性别特异性评估
J Cardiovasc Dev Dis. 2025 Jul 5;12(7):259. doi: 10.3390/jcdd12070259.
3
Evaluation of CHADS-VA Score and Systemic Inflammatory Indexes in Patients with Nonvalvular Atrial Fibrillation: A Case-Control Study.非瓣膜性心房颤动患者CHADS-VA评分与全身炎症指标的评估：一项病例对照研究
J Clin Med. 2025 Jun 29;14(13):4601. doi: 10.3390/jcm14134601.
4
Multifactorial Risk Stratification in Patients with Heart Failure, Chronic Kidney Disease, and Atrial Fibrillation: A Comprehensive Analysis.心力衰竭、慢性肾脏病和心房颤动患者的多因素风险分层：一项综合分析
Life (Basel). 2025 May 14;15(5):786. doi: 10.3390/life15050786.
5
Explainable artificial intelligence for stroke risk stratification in atrial fibrillation.用于心房颤动中风风险分层的可解释人工智能
Eur Heart J Digit Health. 2025 Mar 22;6(3):317-325. doi: 10.1093/ehjdh/ztaf019. eCollection 2025 May.
6
The evolving epidemiological landscape of atrial fibrillation: trends, challenges, and opportunities for improved patient care.心房颤动不断演变的流行病学态势：改善患者护理的趋势、挑战与机遇。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf026.
本文引用的文献
1
Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?CHA2DS2VASc 风险分层方案的精细化：是否应摒弃性别分类标准？
Europace. 2024 Nov 1;26(11). doi: 10.1093/europace/euae280.
2
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.用于心房颤动中风风险预测的CHA2DS2-VASc或非性别评分（CHA2DS2-VA）：当代见解与临床意义。
Eur Heart J. 2024 Sep 29;45(36):3718-3720. doi: 10.1093/eurheartj/ehae540.
3
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).2024年欧洲心脏病学会（ESC）心房颤动管理指南，与欧洲心胸外科学会（EACTS）联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
4
Comparing CHADS-VA and CHADS-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.比较CHADS-VA和CHADS-VASc评分在房颤患者卒中风险分层中的应用：来自芬兰房颤抗凝（FinACAF）回顾性队列的时间趋势分析
Lancet Reg Health Eur. 2024 Jun 10;43:100967. doi: 10.1016/j.lanepe.2024.100967. eCollection 2024 Aug.
5
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry.HAS-BLED 和 DOAC 评分预测直接口服抗凝剂治疗的心房颤动患者主要出血事件的表现：来自前瞻性欧洲观察性登记的报告。
Eur J Intern Med. 2024 Oct;128:63-70. doi: 10.1016/j.ejim.2024.06.022. Epub 2024 Jul 4.
6
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.心房颤动与卒中预防：《欧洲心脏杂志》 25 年研究成果
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad226.
7
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022.2011 年至 2022 年欧洲心脏病学会发布的 50 项临床实践指南的证据水平和推荐类别比较分析。
Eur J Intern Med. 2023 Aug;114:1-14. doi: 10.1016/j.ejim.2023.04.020. Epub 2023 May 9.
8
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).EHRA 专家共识文件：衰弱综合征相关心律失常管理，由心律学会（HRS）、亚太心律学会（APHRS）、拉丁美洲心律学会（LAHRS）和南非心脏节律学会（CASSA）共同认可。
Europace. 2023 Apr 15;25(4):1249-1276. doi: 10.1093/europace/euac123.
9
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019.2019 年全球心房颤动/心房扑动负担及其归因危险因素。
Europace. 2023 Mar 30;25(3):793-803. doi: 10.1093/europace/euac237.
10
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry.当代心房颤动的管理和尽管治疗仍预测与绝对的缺血性卒中风险：来自 ESC-EHRA EORP-AF 长期普通登记处的报告。
Europace. 2023 Feb 16;25(2):277-282. doi: 10.1093/europace/euac214.
Zotero 插件